Related Experiment Video
Updated: Jun 18, 2025
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.
McKenzie Needham1, Rita Pichardo1, Afsaneh Alavi1
1McKenzie Needham and Drs. Pichardo and Strowd are from the Wake Forest University School of Medicine, Winston-Salem, North Carolina. Drs. Pichardo and Strowd also are from the Department of Dermatology, Atrium Health Wake Forest Baptist, Winston-Salem. Dr. Alavi is from the Department of Dermatology, Mayo Clinic, Rochester, Minnesota. Drs. Chang and Fox are from the Department of Dermatology, School of Medicine, University of California San Francisco. Dr. Daveluy is from the School of Medicine, Wayne State University, Detroit, Michigan. Dr. DeNiro is from the Division of Dermatology, Department of Medicine, University of Washington, Seattle. Dr. Dewan is from Vanderbilt University Medical Center, Nashville, Tennessee. Drs. Eshaq and Manusco are from the Department of Dermatology, University of Michigan Medical School, Ann Arbor. Dr. Hsiao is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Kaffenberger is from the Department of Dermatology, Ohio State University, Columbus. Dr. Kirby is from the Department of Dermatology, Penn State Milton S. Hershey Medical Center, Pennsylvania, and Incyte Corporation, Wilmington, Delaware. Drs. Kroshinsky, Mostaghimi, and Porter are from the Department of Dermatology, Harvard Medical School, Boston, Massachusetts. Drs. Kroshinsky and Mostaghimi also are from the Department of Dermatology, Brigham & Women's Hospital, Boston. Dr. Porter also is from the Department of Dermatology, Beth Israel Deaconess Medical Center, Boston. Dr. Ortega-Loayza is from the Department of Dermatology, Oregon Health & Science University, Portland. Dr. Micheletti is from the Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Dr. Nelson is from the Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Dr. Pasieka is from the Department of Dermatology and Medicine, Uniformed Services University, Bethesda, Maryland. Dr. Resnik is from the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Florida. Dr. Sayed is from the Department of Dermatology, University of North Carolina at Chapel Hill. Dr. Shi is from the Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock. Dr. Shields is from the Department of Dermatology, University of Wisconsin, Madison.
Inpatient hospitalizations for hidradenitis suppurativa (HS) are rising. This study developed 40 consensus recommendations to guide healthcare providers in managing severe HS flares during inpatient care.
Area of Science:
- Dermatology
- Inpatient Care Management
- Clinical Practice Guidelines
Background:
- Increasing rates of hidradenitis suppurativa (HS) hospitalizations necessitate improved inpatient management strategies.
- Inpatient healthcare providers may lack specialized knowledge for severe HS and its flares.
- Establishing consensus recommendations is crucial for optimizing holistic inpatient care for HS patients.
Purpose of the Study:
- To develop consensus-based recommendations for the holistic inpatient care of patients with hidradenitis suppurativa (HS).
- To provide a valuable resource for medical professionals managing HS inpatients.
Main Methods:
- A Delphi consensus process involving 26 dermatologists was conducted over two rounds.
- Participants used a 9-point scale to rate 50 proposal statements based on current HS and severe dermatologic disease guidelines.
- The RAND/UCLA Appropriateness Method was employed to determine consensus.
Main Results:
- Forty consensus recommendations for inpatient HS care were generated.
- Twenty-six dermatologists participated in the first round, with 24 completing the second round.
Conclusions:
- The 40 consensus recommendations provide a framework for evidence-based inpatient management of hidradenitis suppurativa.
- These guidelines aim to enhance the quality of care for hospitalized HS patients.
- The recommendations serve as a vital resource for clinicians unfamiliar with managing severe HS in an inpatient setting.
More Related Videos
02:41Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
Published on: May 3, 2024
04:01Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
Published on: September 8, 2022
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:29Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:23Hand hygiene
Hand washing...